2024
A qualitative dyad analysis of barriers and facilitators of antiretroviral therapy (ART) adherence among people who inject drugs (PWID) with HIV in Kazakhstan
Neuenschwander P, Altice F, Remien R, Mergenova G, Sarsembayeva L, Rozental E, Gulyayev V, Davis A. A qualitative dyad analysis of barriers and facilitators of antiretroviral therapy (ART) adherence among people who inject drugs (PWID) with HIV in Kazakhstan. AIDS Care 2024, ahead-of-print: 1-10. PMID: 39404196, DOI: 10.1080/09540121.2024.2414078.Peer-Reviewed Original ResearchAntiretroviral therapy adherenceSocial supportART adherenceFacilitators of ART adherenceBarriers to ART adherenceAntiretroviral therapyART adherence interventionsInjection drug useDyad analysisAdherence interventionsAdherence barriersLack of awarenessHIV epidemicAdherencePWIDDrug useHIVInterpersonal levelRelationship contextDyad membersFacilitationIndividual levelPWHDyadsIntimate partners
2022
Implementation of a Dyad-Based Intervention to Improve Antiretroviral Therapy Adherence Among HIV-Positive People Who Inject Drugs in Kazakhstan: A Randomized Trial
Davis A, Mergenova G, Landers S, Sun Y, Rozental E, Gulyaev V, Gulyaev P, Nurkatova M, Terlikbayeva A, Primbetova S, Altice F, Remien R. Implementation of a Dyad-Based Intervention to Improve Antiretroviral Therapy Adherence Among HIV-Positive People Who Inject Drugs in Kazakhstan: A Randomized Trial. Research On Social Work Practice 2022, 33: 313-324. PMID: 37576461, PMCID: PMC10421639, DOI: 10.1177/10497315221117543.Peer-Reviewed Original ResearchHIV-positive PWIDAntiretroviral therapy adherenceHIV-positive peopleTherapy adherenceART adherence interventionsStandard of careSupport partnersART adherenceAdherence interventionsIntervention deliveryPWIDTraining of staffInterventionTrialsAdherenceCouple interventionsSocial supportFamily membersDrugsIntimate partnersRemote deliveryCollection of assessmentsImplementation strategiesDeliveryAdapted version
2016
Acceptability and feasibility of mHealth and community-based directly observed antiretroviral therapy to prevent mother-to-child HIV transmission in South African pregnant women under Option B+: an exploratory study
Nachega JB, Skinner D, Jennings L, Magidson JF, Altice FL, Burke JG, Lester RT, Uthman OA, Knowlton AR, Cotton MF, Anderson JR, Theron GB. Acceptability and feasibility of mHealth and community-based directly observed antiretroviral therapy to prevent mother-to-child HIV transmission in South African pregnant women under Option B+: an exploratory study. Patient Preference And Adherence 2016, Volume 10: 683-690. PMID: 27175068, PMCID: PMC4854240, DOI: 10.2147/ppa.s100002.Peer-Reviewed Original ResearchFeasibility of mHealthHIV status disclosurePregnant womenAntiretroviral therapyTreatment supportersStatus disclosureChild human immunodeficiency virus (HIV) transmissionCommunity primary care clinicsHuman immunodeficiency virus (HIV) transmissionPregnant South African womenART adherence interventionsAntiretroviral therapy regimenChild HIV transmissionAntiretroviral therapy adherencePrimary care clinicsSouth African pregnant womenMobile phone accessAfrican pregnant womenFocus group discussionsSMS text messagingPMTCT servicesSouth African womenART adherencePhone accessTherapy regimen